Showing results (111-120 of 203) with videos related to
Sort By:
Pageof 21
Annals of Surgical Oncology|July 17, 2023
Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node DissectionShruti Zaveri, Shlermine Everidge, Elizabeth FitzSullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.Cancers|July 29, 2023
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III MelanomaAnthony Lucci, Sridevi Addanki, Yi-Ju Chiang, et al.Annals of Surgical Oncology|July 19, 2022
Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal TreatmentClara R Farley, Shelby Irwin, Taiwo Adesoye, et al.Journal of the National Cancer Institute|September 17, 2015
Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast CancerCarolyn S Hall, Mandar Karhade, Barbara A Laubacher, et al.Annals of Surgical Oncology|May 2, 2025
Characterization of the Germline Pathogenic Mutational Landscape and Oncologic Outcomes Among 877 Patients with Invasive Lobular CarcinomaVictoria D Huynh, Jason Mouabbi, Henry M Kuerer, et al.The Oncologist|May 16, 2012
Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi, Wendy A Woodward, Vicente Valero, et al.Clinical Breast Cancer|January 13, 2004
Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary resultsAndrea E Van Pelt, Syed Mohsin, Richard M Elledge, et al.Annals of Surgical Oncology|July 3, 2026
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular CarcinomaGenevieve A Fasano, Jason Mouabbi, Helen M Johnson, et al.Cancer|June 22, 2010
Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancerLaura S Dominici, Viviana M Negron Gonzalez, Aman U Buzdar, et al.Pageof 21